Company Unveils Latest Offerings at ECCMID
Becton, Dickinson and Company (BD) recently introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance.
The new molecular, microbiology, and software solutions were unveiled and showcased at the recent European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain.
“BD understands our lab needs an advanced informatics solution that supports integrated workflow across lab instruments, with access to data across all systems to better utilize our resources, reduce turnaround times and error rates, and show efficiency data in order to maximize the usage of our instrumentation to ultimately allow us to better serve our physicians and patients,” said Alanna Emrick, Microbiology Manager at UMC Health System.
Also to be unveiled at the BD booth at ECCMID:
- BD COR™ system, a new high-throughput molecular platform designed to support a menu of clinically differentiated assays for women’s health, sexually transmitted infections and gastrointestinal (GI) applications.
- BD’s Kiestra ID/AST module, a new additions to the BD Kiestra solution that automates the processing steps for bacterial identification and antibiotic susceptibility testing using the BD Bruker MALDI and BD Phoenix™ systems.